Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
John P. Kenny Insider Profile
4 Followers
John P. Kenny, CEO, Director, Ten Percent Owner at Meridian Bioscience, holds 23.26K shares in Orasure Technologies (Ticker: OSUR), holds 114.28K shares in Quantum-Si (Ticker: QSI), holds 0.00 shares in Meridian Bioscience (Ticker: VIVO).
John P. Kenny Meridian Bioscience (VIVO)CEO, Director, Ten Percent Owner
Meridian Bioscience (VIVO)
CEO, Director, Ten Percent Owner
Ranked #2,273 out of 100,285 Corporate Insiders
Profitable Transactions
4 out of 4 Profitable Transactions
Average Return
+151.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John P. Kenny holds in companies
Most Profitable Insider Trade
Stock:
Meridian Bioscience
(VIVO)
(VIVO)
Rating:Informative Buy
Date:Mar 13, 2020 - Mar 13, 2021
Return:+275.30%
The most profitable trade made by John P. Kenny
John P. Kenny's Trading History
Meridian Bioscience
Jan 31, 2023
―
Uninformative Sell
―
$0.00
Quantum-Si
May 24, 2023
Director
Uninformative Buy
―
$256.00K
Biomerica
―
Director
―
$0.00
Orasure Technologies
Sep 10, 2024
Director
Uninformative Buy
100.00K
$84.88K
List of latest transactions for each holding click on a transaction to see John P. Kenny's performance on stock
You May Also Like
John P. Kenny insider profile FAQ
What is the percentage of profitable transactions made by John P. Kenny?
The percentage of profitable transactions made by John P. Kenny is 100%.
What is the average return per transaction made by John P. Kenny?
The average return per transaction made by John P. Kenny is 151.50%.
What stocks does John P. Kenny hold?
John P. Kenny holds: VIVO, QSI, BMRA, OSUR stocks.
What was John P. Kenny’s latest transaction?
John P. Kenny latest transaction was an Uninformative Buy of $100.00K.
What was John P. Kenny's most profitable transaction?
John P. Kenny’s most profitable transaction was an Informative Buy of VIVO stock on March 13, 2020. The return on the trade was 275.30%.
What is John P. Kenny's role in Meridian Bioscience?
John P. Kenny's role in Meridian Bioscience is CEO, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.